_×
Human COMP / THBS5 Gene cDNA Clone (full-length ORF Clone)
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Gene Products > Human cDNA Clones > Human COMP / THBS5 Gene cDNA Clone (full-length ORF Clone)

Human COMP / THBS5 Gene cDNA Clone (full-length ORF Clone)

Catalog Vector (Price) Quantity In Stock Operation
HG10173-M





  YES

*  pCMV vectors are ALL featured with a CMV promoter and a hygromycin-resistance (hygro) gene. These plasmids can be used directly in mammalian cell expression. Learn more about pCMV vectors.
    Notice: Additional handling time(2-3 weeks) may be required if a pCMV vector is selected.

Antibody Production Services

Manufactured By: Sino Biological Inc.

Gene Bank Ref.ID:   NM_000095.2

cDNA Size:   2274

Synonym:   COMP, MED, EDM1, EPD1, PSACH, THBS5, MGC131819, MGC149768

Source:  Human.

cDNA Description:   ORF Clone of Homo sapiens cartilage oligomeric matrix protein DNA

Vector: Cloning Vector: pMD18-T Simple Vector.

Expression Vectors: pCMV/hygro, pCMV/hygro-Myc, pCMV/hygro-His, pCMV/hygro-HA, pCMV/hygro-FLAG


Sequence Description:   Identical with the Gene Bank Ref. ID sequence except for the point mutation 2272-2274 TAG/TAA not causing the amino acid variation.

5-10μg Plasmid DNA is shipped on Whatman FTA elute card (Cat. No.: WB120410) at room temperature.
It would take 7-14 days for delivery typically. For bulk orders, additional 1-2 weeks would be needed.

  1. Cut along the circle edge of the spot (arrow points to) to get the filter paper.
  2. Transfer the filter paper to a 1.5ml microfuge tube containing 150-200 μl of sterile H2O . Ensure the filter paper is completely immersed in the H2O Briefly centrifuge the tube for 10 seconds.
  3. Incubate the tube at 95℃ for 15-30 min.
  4. At the end of the incubation pulse vortex, or gently tap the tube.
  5. Briefly centrifuge for 30 seconds, to separate the scattered filter paper from the elute. The elute now contains the purified DNA .
Sequence:

1        NUCLETIDES EQUENCEATG GTCCCCGACA CCGCCTGCGT TCTTCTGCTC ACCCTGGCTG
61       CCCTCGGCGC GTCCGGACAG GGCCAGAGCC CGTTGGGCTC AGACCTGGGC CCGCAGATGC
121      TTCGGGAACT GCAGGAAACC AACGCGGCGC TGCAGGACGT GCGGGAGCTG CTGCGGCAGC
181      AGGTCAGGGA GATCACGTTC CTGAAAAACA CGGTGATGGA GTGTGACGCG TGCGGGATGC
241      AGCAGTCAGT ACGCACCGGC CTACCCAGCG TGCGGCCCCT GCTCCACTGC GCGCCCGGCT
301      TCTGCTTCCC CGGCGTGGCC TGCATCCAGA CGGAGAGCGG CGCGCGCTGC GGCCCCTGCC
361      CCGCGGGCTT CACGGGCAAC GGCTCGCACT GCACCGACGT CAACGAGTGC AACGCCCACC
421      CCTGCTTCCC CCGAGTCCGC TGTATCAACA CCAGCCCGGG GTTCCGCTGC GAGGCTTGCC
481      CGCCGGGGTA CAGCGGCCCC ACCCACCAGG GCGTGGGGCT GGCTTTCGCC AAGGCCAACA
541      AGCAGGTTTG CACGGACATC AACGAGTGTG AGACCGGGCA ACATAACTGC GTCCCCAACT
601      CCGTGTGCAT CAACACCCGG GGCTCCTTCC AGTGCGGCCC GTGCCAGCCC GGCTTCGTGG
661      GCGACCAGGC GTCCGGCTGC CAGCGGCGCG CACAGCGCTT CTGCCCCGAC GGCTCGCCCA
721      GCGAGTGCCA CGAGCATGCA GACTGCGTCC TAGAGCGCGA TGGCTCGCGG TCGTGCGTGT
781      GTGCCGTTGG CTGGGCCGGC AACGGGATCC TCTGTGGTCG CGACACTGAC CTAGACGGCT
841      TCCCGGACGA GAAGCTGCGC TGCCCGGAGC GCCAGTGCCG TAAGGACAAC TGCGTGACTG
901      TGCCCAACTC AGGGCAGGAG GATGTGGACC GCGATGGCAT CGGAGACGCC TGCGATCCGG
961      ATGCCGACGG GGACGGGGTC CCCAATGAAA AGGACAACTG CCCGCTGGTG CGGAACCCAG
1021     ACCAGCGCAA CACGGACGAG GACAAGTGGG GCGATGCGTG CGACAACTGC CGGTCCCAGA
1081     AGAACGACGA CCAAAAGGAC ACAGACCAGG ACGGCCGGGG CGATGCGTGC GACGACGACA
1141     TCGACGGCGA CCGGATCCGC AACCAGGCCG ACAACTGCCC TAGGGTACCC AACTCAGACC
1201     AGAAGGACAG TGATGGCGAT GGTATAGGGG ATGCCTGTGA CAACTGTCCC CAGAAGAGCA
1261     ACCCGGATCA GGCGGATGTG GACCACGACT TTGTGGGAGA TGCTTGTGAC AGCGATCAAG
1321     ACCAGGATGG AGACGGACAT CAGGACTCTC GGGACAACTG TCCCACGGTG CCTAACAGTG
1381     CCCAGGAGGA CTCAGACCAC GATGGCCAGG GTGATGCCTG CGACGACGAC GACGACAATG
1441     ACGGAGTCCC TGACAGTCGG GACAACTGCC GCCTGGTGCC TAACCCCGGC CAGGAGGACG
1501     CGGACAGGGA CGGCGTGGGC GACGTGTGCC AGGACGACTT TGATGCAGAC AAGGTGGTAG
1561     ACAAGATCGA CGTGTGTCCG GAGAACGCTG AAGTCACGCT CACCGACTTC AGGGCCTTCC
1621     AGACAGTCGT GCTGGACCCG GAGGGTGACG CGCAGATTGA CCCCAACTGG GTGGTGCTCA
1681     ACCAGGGAAG GGAGATCGTG CAGACAATGA ACAGCGACCC AGGCCTGGCT GTGGGTTACA
1741     CTGCCTTCAA TGGCGTGGAC TTCGAGGGCA CGTTCCATGT GAACACGGTC ACGGATGACG
1801     ACTATGCGGG CTTCATCTTT GGCTACCAGG ACAGCTCCAG CTTCTACGTG GTCATGTGGA
1861     AGCAGATGGA GCAAACGTAT TGGCAGGCGA ACCCCTTCCG TGCTGTGGCC GAGCCTGGCA
1921     TCCAACTCAA GGCTGTGAAG TCTTCCACAG GCCCCGGGGA ACAGCTGCGG AACGCTCTGT
1981     GGCATACAGG AGACACAGAG TCCCAGGTGC GGCTGCTGTG GAAGGACCCG CGAAACGTGG
2041     GTTGGAAGGA CAAGAAGTCC TATCGTTGGT TCCTGCAGCA CCGGCCCCAA GTGGGCTACA
2101     TCAGGGTGCG ATTCTATGAG GGCCCTGAGC TGGTGGCCGA CAGCAACGTG GTCTTGGACA
2161     CAACCATGCG GGGTGGCCGC CTGGGGGTCT TCTGCTTCTC CCAGGAGAAC ATCATCTGGG
2221     CCAACCTGCG TTACCGCTGC AATGACACCA TCCCAGAGGA CTATGAGACC CATCAGCTGC
2281     GGCAAGCCTA A


Quality Control:   cDNA sequencing results is available upon request.

 

Cartilage Oligomeric Matrix Protein/COMP related areas, pathways, and other information

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"